About
Dermagnostix is a medtech company based in Freiburg, Germany, specializing in innovative molecular diagnostic solutions for dermatology. Founded in 2021 as a spin-off from the Hahn-Schickard Institute, Helmholtz Zentrum München, and the Technical University of Munich, the company focuses on bridging the gap between advanced dermatological therapies and traditional diagnostic methods. The flagship product, PsorX-LabDisk, is the first molecular test that differentiates between psoriasis and eczema using gene expression markers. This test is performed on a disposable LabDisk cartridge, allowing for quick and reliable results at the point of need. Dermagnostix also offers a modular microfluidic platform and fluorescence detection technology, enhancing their capabilities in diagnostics and research. Their target customers include dermatologists, diagnostic laboratories, and research organizations, all seeking accurate and rapid molecular diagnostics for skin health. The company aims to advance dermatology diagnostics and improve patient outcomes through objective molecular results.
Technologies
Keywords
Company Information
- Employees37
- Founded2021
Location
Freiburg, Baden-Wuerttemberg, Germany
